SEC Form 4 · accession 0001628280-26-058583
OptimizeRx Corp · OPRX
Statement of changes in beneficial ownership, as filed. Original on EDGAR ↗
Reporting owner
Edward Stelmakh
Officer — Chief Finance & Strat Officer
Period of report
Aug 21, 2026
Accepted (ET)
Aug 24, 2026 · 3:11 pm EDT
Rule 10b5-1 plan
box not checked
Issuer CIK
0001448431
Table I — non-derivative securities
| Security | Date | Code | Shares | Price | A/D | Owned after | D/I | Nature of ownership |
|---|---|---|---|---|---|---|---|---|
| Common StockF1 | Aug 21, 2026 | F | 1,381 | $7.71 | D | 121,791 | D |
Table II — derivative securities
No Table II lines on this filing.
Explanation of responses
- F1The filing of this Statement shall not be construed as an admission (a) that the person filing this Statement is, for the purposes of Section 16 of the Securities Exchange Act of 1934, as amended, the beneficial owner of any equity securities covered by this Statement, or (b) that this Statement is legally required to be filed by such person.
Remarks
The filing of this Statement shall not be construed as an admission (a) that the person filing this Statement is, for the purposes of Section 16 of the Securities Exchange Act of 1934, as amended, the beneficial owner of any equity securities covered by this Statement, or (b) that this Statement is legally required to be filed by such person.